Precision Biosciences (DTIL) Operating Margin (2018 - 2025)
Historic Operating Margin for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to 158976.92%.
- Precision Biosciences' Operating Margin fell 1552833500.0% to 158976.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 12822.64%, marking a year-over-year decrease of 128010600.0%. This contributed to the annual value of 38.08% for FY2024, which is 516700.0% up from last year.
- According to the latest figures from Q3 2025, Precision Biosciences' Operating Margin is 158976.92%, which was down 1552833500.0% from 121538.89% recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' Operating Margin registered a high of 48.39% during Q2 2024, and its lowest value of 158976.92% during Q3 2025.
- In the last 5 years, Precision Biosciences' Operating Margin had a median value of 199.32% in 2022 and averaged 19333.07%.
- As far as peak fluctuations go, Precision Biosciences' Operating Margin surged by 30748500bps in 2021, and later plummeted by -1552833500bps in 2025.
- Precision Biosciences' Operating Margin (Quarter) stood at 484.68% in 2021, then skyrocketed by 76bps to 114.26% in 2022, then tumbled by -85bps to 211.57% in 2023, then crashed by -1741bps to 3894.36% in 2024, then plummeted by -3982bps to 158976.92% in 2025.
- Its last three reported values are 158976.92% in Q3 2025, 121538.89% for Q2 2025, and 76248.28% during Q1 2025.